全文获取类型
收费全文 | 4699篇 |
免费 | 331篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 151篇 |
妇产科学 | 96篇 |
基础医学 | 539篇 |
口腔科学 | 113篇 |
临床医学 | 645篇 |
内科学 | 876篇 |
皮肤病学 | 42篇 |
神经病学 | 461篇 |
特种医学 | 152篇 |
外科学 | 538篇 |
综合类 | 51篇 |
一般理论 | 7篇 |
预防医学 | 663篇 |
眼科学 | 55篇 |
药学 | 318篇 |
中国医学 | 8篇 |
肿瘤学 | 286篇 |
出版年
2023年 | 33篇 |
2022年 | 44篇 |
2021年 | 95篇 |
2020年 | 80篇 |
2019年 | 86篇 |
2018年 | 94篇 |
2017年 | 79篇 |
2016年 | 105篇 |
2015年 | 104篇 |
2014年 | 145篇 |
2013年 | 225篇 |
2012年 | 328篇 |
2011年 | 307篇 |
2010年 | 152篇 |
2009年 | 144篇 |
2008年 | 306篇 |
2007年 | 285篇 |
2006年 | 276篇 |
2005年 | 268篇 |
2004年 | 265篇 |
2003年 | 249篇 |
2002年 | 228篇 |
2001年 | 52篇 |
2000年 | 64篇 |
1999年 | 66篇 |
1998年 | 47篇 |
1997年 | 45篇 |
1996年 | 31篇 |
1995年 | 37篇 |
1994年 | 43篇 |
1993年 | 29篇 |
1992年 | 47篇 |
1991年 | 47篇 |
1990年 | 42篇 |
1989年 | 53篇 |
1988年 | 43篇 |
1987年 | 44篇 |
1986年 | 30篇 |
1985年 | 28篇 |
1984年 | 27篇 |
1983年 | 35篇 |
1981年 | 18篇 |
1980年 | 21篇 |
1979年 | 22篇 |
1978年 | 19篇 |
1976年 | 19篇 |
1974年 | 23篇 |
1971年 | 28篇 |
1970年 | 21篇 |
1969年 | 18篇 |
排序方式: 共有5037条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
96.
97.
98.
Aaron M. Samuels Elizabeth Matey Pauline N. M. Mwinzi Ryan E. Wiegand Geoffrey Muchiri Edmund Ireri Molly Hyde Susan P. Montgomery Diana M. S. Karanja W. Evan Secor 《The American journal of tropical medicine and hygiene》2012,87(5):874-882
Schistosomiasis control programs aim to reduce morbidity but are evaluated by infection prevalence and intensity reduction. We present baseline cross-sectional data from a nested cohort study comparing indicators of morbidity for measuring program impact. Eight hundred twenty-two schoolchildren 7–8 years of age from Nyanza Province, Kenya, contributed stool for diagnosis of Schistosoma mansoni and soil-transmitted helminths (STH) and blood smears for malaria, and were evaluated for anemia, quality of life, exercise tolerance, anthropometry, and ultrasound abnormalities. Schistosoma mansoni, STH, and malaria infection prevalence were 69%, 25%, and 8%, respectively. Only anemia and S. mansoni infection (adjusted odds ratio [aOR] = 1.70; confidence interval [CI] = 1.03–2.80), and hepatomegaly and heavy S. mansoni infection (aOR = 2.21; CI = 1.19–4.11) were associated. Though anemia and hepatomegaly appeared most useful at baseline, additional morbidity indicators may be sensitive longitudinal measures to evaluate schistosomiasis program health impact. 相似文献
99.
Nieborowska-Skorska M Kopinski PK Ray R Hoser G Ngaba D Flis S Cramer K Reddy MM Koptyra M Penserga T Glodkowska-Mrowka E Bolton E Holyoake TL Eaves CJ Cerny-Reiterer S Valent P Hochhaus A Hughes TP van der Kuip H Sattler M Wiktor-Jedrzejczak W Richardson C Dorrance A Stoklosa T Williams DA Skorski T 《Blood》2012,119(18):4253-4263
Chronic myeloid leukemia in chronic phase (CML-CP) is induced by BCR-ABL1 oncogenic tyrosine kinase. Tyrosine kinase inhibitors eliminate the bulk of CML-CP cells, but fail to eradicate leukemia stem cells (LSCs) and leukemia progenitor cells (LPCs) displaying innate and acquired resistance, respectively. These cells may accumulate genomic instability, leading to disease relapse and/or malignant progression to a fatal blast phase. In the present study, we show that Rac2 GTPase alters mitochondrial membrane potential and electron flow through the mitochondrial respiratory chain complex III (MRC-cIII), thereby generating high levels of reactive oxygen species (ROS) in CML-CP LSCs and primitive LPCs. MRC-cIII-generated ROS promote oxidative DNA damage to trigger genomic instability, resulting in an accumulation of chromosomal aberrations and tyrosine kinase inhibitor-resistant BCR-ABL1 mutants. JAK2(V617F) and FLT3(ITD)-positive polycythemia vera cells and acute myeloid leukemia cells also produce ROS via MRC-cIII. In the present study, inhibition of Rac2 by genetic deletion or a small-molecule inhibitor and down-regulation of mitochondrial ROS by disruption of MRC-cIII, expression of mitochondria-targeted catalase, or addition of ROS-scavenging mitochondria-targeted peptide aptamer reduced genomic instability. We postulate that the Rac2-MRC-cIII pathway triggers ROS-mediated genomic instability in LSCs and primitive LPCs, which could be targeted to prevent the relapse and malignant progression of CML. 相似文献
100.